Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 535

1.

Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017.

Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, Finfer S, Pelosi P, Brazzi L, Aditianingsih D, Timsit JF, Du B, Wittebole X, Máca J, Kannan S, Gorordo-Delsol LA, De Waele JJ, Mehta Y, Bonten MJM, Khanna AK, Kollef M, Human M, Angus DC; EPIC III Investigators.

JAMA. 2020 Mar 24. doi: 10.1001/jama.2020.2717. [Epub ahead of print]

PMID:
32207816
2.

Impact of antimicrobial de-escalation on mortality: a literature review of study methodology and recommendations for observational studies.

Van Heijl I, Schweitzer VA, Van Der Linden PD, Bonten MJM, Van Werkhoven CH.

Expert Rev Anti Infect Ther. 2020 Mar 21:1-9. doi: 10.1080/14787210.2020.1743683. [Epub ahead of print]

PMID:
32178545
3.

The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function.

Doesschate TT, van Haren E, Wijma RA, Koch BCP, Bonten MJM, van Werkhoven CH.

Clin Microbiol Infect. 2020 Mar 9. pii: S1198-743X(20)30143-9. doi: 10.1016/j.cmi.2020.03.001. [Epub ahead of print]

4.

Nonclonal Emergence of Colistin Resistance Associated with Mutations in the BasRS Two-Component System in Escherichia coli Bloodstream Isolates.

Janssen AB, Bartholomew TL, Marciszewska NP, Bonten MJM, Willems RJL, Bengoechea JA, van Schaik W.

mSphere. 2020 Mar 11;5(2). pii: e00143-20. doi: 10.1128/mSphere.00143-20.

5.

Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial.

Maechler F, Schwab F, Hansen S, Fankhauser C, Harbarth S, Huttner BD, Diaz-Agero C, Lopez N, Canton R, Ruiz-Garbajosa P, Blok H, Bonten MJ, Kloosterman F, Schotsman J, Cooper BS, Behnke M, Golembus J, Kola A, Gastmeier P; R-GNOSIS WP5 study group.

Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(19)30626-7. doi: 10.1016/S1473-3099(19)30626-7. [Epub ahead of print]

PMID:
32087113
6.

Seasonality in carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in the general population: a pooled analysis of nationwide cross-sectional studies.

Wielders CCH, Van Duijkeren E, Van Den Bunt G, Meijs AP, Dierikx CM, Bonten MJM, Van Pelt W, Franz E, De Greeff SC.

Epidemiol Infect. 2020 Feb 21;148:e68. doi: 10.1017/S0950268820000539.

PMID:
32081112
7.

Occurrence and Risk Factors of Chronic Pain After Critical Illness.

Koster-Brouwer ME, Rijsdijk M, van Os WKM, Soliman IW, Slooter AJC, de Lange DW, van Dijk D, Bonten MJM, Cremer OL.

Crit Care Med. 2020 Feb 10. doi: 10.1097/CCM.0000000000004259. [Epub ahead of print]

PMID:
32039992
8.

Correction to: Predicting the clinical trajectory in critically ill patients with sepsis: a cohort study.

Klein Klouwenberg PMC, Spitoni C, van der Poll T, Bonten MJ, Cremer OL; MARS consortium.

Crit Care. 2020 Feb 6;24(1):41. doi: 10.1186/s13054-020-2758-1.

9.

Extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli isolates causing bacteremia in the Netherlands (2014 - 2016) differ in clonal distribution, antimicrobial resistance gene and virulence gene content.

van Hout D, Verschuuren TD, Bruijning-Verhagen PCJ, Bosch T, Schürch AC, Willems RJL, Bonten MJM, Kluytmans JAJW.

PLoS One. 2020 Jan 14;15(1):e0227604. doi: 10.1371/journal.pone.0227604. eCollection 2020.

10.

Preemptive Treatment of Herpes Simplex Virus Reactivation in Critically Ill Patients?-Not Based on Current Data.

Ong DSY, Cremer OL, Bonten MJM.

JAMA Intern Med. 2019 Dec 16. doi: 10.1001/jamainternmed.2019.6423. [Epub ahead of print] No abstract available.

PMID:
31841575
11.

Predicting the clinical trajectory in critically ill patients with sepsis: a cohort study.

Klein Klouwenberg PMC, Spitoni C, van der Poll T, Bonten MJ, Cremer OL; MARS consortium.

Crit Care. 2019 Dec 12;23(1):408. doi: 10.1186/s13054-019-2687-z. Erratum in: Crit Care. 2020 Feb 6;24(1):41.

12.

Selective decontamination of the digestive tract (SDD) in critically ill patients: a narrative review.

Wittekamp BHJ, Oostdijk EAN, Cuthbertson BH, Brun-Buisson C, Bonten MJM.

Intensive Care Med. 2020 Feb;46(2):343-349. doi: 10.1007/s00134-019-05883-9. Epub 2019 Dec 9. Review.

13.

Faecal carriage, risk factors, acquisition and persistence of ESBL-producing Enterobacteriaceae in dogs and cats and co-carriage with humans belonging to the same household.

van den Bunt G, Fluit AC, Spaninks MP, Timmerman AJ, Geurts Y, Kant A, Scharringa J, Mevius D, Wagenaar JA, Bonten MJM, van Pelt W, Hordijk J.

J Antimicrob Chemother. 2020 Feb 1;75(2):342-350. doi: 10.1093/jac/dkz462.

14.

The added value of the selective SuperPolymyxin™ medium in detecting rectal carriage of Gram-negative bacteria with acquired colistin resistance in intensive care unit patients receiving selective digestive decontamination.

van Hout D, Janssen AB, Rentenaar RJ, Vlooswijk JPM, Boel CHE, Bonten MJM.

Eur J Clin Microbiol Infect Dis. 2020 Feb;39(2):265-271. doi: 10.1007/s10096-019-03718-5. Epub 2019 Nov 6.

15.

Dynamics of intestinal carriage of Extended-spectrum Beta-lactamase producing Enterobacteriaceae in the Dutch general population (2014-2016).

van den Bunt G, Fluit AC, Bootsma MCJ, Duijkeren EV, Scharringa J, Pelt WV, Bonten MJM.

Clin Infect Dis. 2019 Nov 5. pii: ciz1091. doi: 10.1093/cid/ciz1091. [Epub ahead of print]

PMID:
31688916
16.

Increased mortality in elderly patients with acute respiratory distress syndrome is not explained by host response.

Schouten LRA, Bos LDJ, Serpa Neto A, van Vught LA, Wiewel MA, Hoogendijk AJ, Bonten MJM, Cremer OL, Horn J, van der Poll T, Schultz MJ, Wösten-van Asperen RM; MARS consortium.

Intensive Care Med Exp. 2019 Oct 29;7(1):58. doi: 10.1186/s40635-019-0270-1.

17.

Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.

van den Bunt G, van Pelt W, Hidalgo L, Scharringa J, de Greeff SC, Schürch AC, Mughini-Gras L, Bonten MJM, Fluit AC.

Euro Surveill. 2019 Oct;24(41). doi: 10.2807/1560-7917.ES.2019.24.41.1800594.

18.

Sequence-based epidemiology of an OXA-48 plasmid during a hospital outbreak.

Hidalgo L, de Been M, Rogers MRC, Schürch AC, Scharringa J, van der Zee A, Bonten MJM, Fluit AC.

Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01204-19. doi: 10.1128/AAC.01204-19. [Epub ahead of print]

PMID:
31591122
19.

Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort.

van Heijl I, Schweitzer VA, Boel CHE, Oosterheert JJ, Huijts SM, Dorigo-Zetsma W, van der Linden PD, Bonten MJM, van Werkhoven CH.

PLoS One. 2019 Sep 27;14(9):e0218062. doi: 10.1371/journal.pone.0218062. eCollection 2019.

20.

Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis.

Ten Doesschate T, Groenwold RHH, Bonten MJM, van Werkhoven CH.

J Antimicrob Chemother. 2019 Nov 1;74(11):3337-3343. doi: 10.1093/jac/dkz350.

21.

Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance: an individual patient data meta-analysis.

van Hout D, Plantinga NL, Bruijning-Verhagen PC, Oostdijk EAN, de Smet AMGA, de Wit GA de, Bonten MJM, van Werkhoven CH.

BMJ Open. 2019 Sep 6;9(9):e028876. doi: 10.1136/bmjopen-2018-028876.

22.

Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group.

Schweitzer VA, van Werkhoven CH, Rodríguez Baño J, Bielicki J, Harbarth S, Hulscher M, Huttner B, Islam J, Little P, Pulcini C, Savoldi A, Tacconelli E, Timsit JF, van Smeden M, Wolkewitz M, Bonten MJM, Walker AS, Llewelyn MJ; Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) Working Group on Design of Antimicrobial Stewardship Evaluations.

Clin Microbiol Infect. 2020 Jan;26(1):41-50. doi: 10.1016/j.cmi.2019.08.017. Epub 2019 Sep 4.

23.

Robustness of sepsis-3 criteria in critically ill patients.

Verboom DM, Frencken JF, Ong DSY, Horn J, van der Poll T, Bonten MJM, Cremer OL, Klein Klouwenberg PMC.

J Intensive Care. 2019 Aug 29;7:46. doi: 10.1186/s40560-019-0400-6. eCollection 2019.

24.

Contact precautions in single-bed or multiple-bed rooms for patients with extended-spectrum β-lactamase-producing Enterobacteriaceae in Dutch hospitals: a cluster-randomised, crossover, non-inferiority study.

Kluytmans-van den Bergh MFQ, Bruijning-Verhagen PCJ, Vandenbroucke-Grauls CMJE, de Brauwer EIGB, Buiting AGM, Diederen BM, van Elzakker EPM, Friedrich AW, Hopman J, Al Naiemi N, Rossen JWA, Ruijs GJHM, Savelkoul PHM, Verhulst C, Vos MC, Voss A, Bonten MJM, Kluytmans JAJW; SoM Study Group.

Lancet Infect Dis. 2019 Oct;19(10):1069-1079. doi: 10.1016/S1473-3099(19)30262-2. Epub 2019 Aug 23.

PMID:
31451419
25.

Attributable sources of community-acquired carriage of Escherichia coli containing β-lactam antibiotic resistance genes: a population-based modelling study.

Mughini-Gras L, Dorado-García A, van Duijkeren E, van den Bunt G, Dierikx CM, Bonten MJM, Bootsma MCJ, Schmitt H, Hald T, Evers EG, de Koeijer A, van Pelt W, Franz E, Mevius DJ, Heederik DJJ; ESBL Attribution Consortium.

Lancet Planet Health. 2019 Aug;3(8):e357-e369. doi: 10.1016/S2542-5196(19)30130-5. Erratum in: Lancet Planet Health. 2019 Oct;3(10):e408.

26.

The effects of topical antibiotics on eradication and acquisition of third-generation cephalosporin and carbapenem-resistant Gram-negative bacteria in ICU patients; a post hoc analysis from a multicentre cluster-randomized trial.

Plantinga NL, Wittekamp BHJ, Brun-Buisson C, Bonten MJM; R-GNOSIS ICU study group.

Clin Microbiol Infect. 2019 Aug 14. pii: S1198-743X(19)30440-9. doi: 10.1016/j.cmi.2019.08.001. [Epub ahead of print]

PMID:
31421272
27.

A pilot study of a novel molecular host response assay to diagnose infection in patients after high-risk gastro-intestinal surgery.

Verboom DM, Koster-Brouwer ME, Ruurda JP, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Scicluna BP, Bonten MJM, Cremer OL; MARS consortium.

J Crit Care. 2019 Dec;54:83-87. doi: 10.1016/j.jcrc.2019.07.020. Epub 2019 Jul 30.

28.

Roux-Y Gastric Bypass and Sleeve Gastrectomy directly change gut microbiota composition independent of surgery type.

Paganelli FL, Luyer M, Hazelbag CM, Uh HW, Rogers MRC, Adriaans D, Berbers RM, Hendrickx APA, Viveen MC, Groot JA, Bonten MJM, Fluit AC, Willems RJL, Leavis HL.

Sci Rep. 2019 Jul 29;9(1):10979. doi: 10.1038/s41598-019-47332-z.

29.

Plasma cytokine profile on admission related to aetiology in community-acquired pneumonia.

Burgmeijer EH, Duijkers R, Lutter R, Bonten MJM, Schweitzer VA, Boersma WG.

Clin Respir J. 2019 Oct;13(10):605-613. doi: 10.1111/crj.13062. Epub 2019 Aug 16.

PMID:
31310442
30.

Moderate positive predictive value of a multiplex real-time PCR on whole blood for pathogen detection in critically ill patients with sepsis.

van de Groep K, Bos MP, Varkila MRJ, Savelkoul PHM, Ong DSY, Derde LPG, Juffermans NP, van der Poll T, Bonten MJM, Cremer OL; MARS consortium.

Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1829-1836. doi: 10.1007/s10096-019-03616-w. Epub 2019 Jun 26.

31.

Matrix metalloproteinase-8: a useful biomarker to refine the diagnosis of community-acquired pneumonia upon intensive care unit admission?

Uhel F, Scicluna BP, van Vught LA, Cremer OL, Bonten MJ, Schultz MJ, van der Poll T.

Crit Care. 2019 Jun 20;23(1):226. doi: 10.1186/s13054-019-2513-7. No abstract available.

32.

A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.

Gessner BD, Jiang Q, Van Werkhoven CH, Sings HL, Webber C, Scott D, Gruber WC, Grobbee DE, Bonten MJM, Jodar L.

Vaccine. 2019 Jul 9;37(30):4147-4154. doi: 10.1016/j.vaccine.2019.05.065. Epub 2019 May 31.

33.

Epidemiology and outcomes of source control procedures in critically ill patients with intra-abdominal infection.

van de Groep K, Verhoeff TL, Verboom DM, Bos LD, Schultz MJ, Bonten MJM, Cremer OL; MARS consortium.

J Crit Care. 2019 Aug;52:258-264. doi: 10.1016/j.jcrc.2019.02.029. Epub 2019 May 1.

PMID:
31054787
34.

Detection of Invasive Aspergillosis in Critically Ill Patients with Influenza: The Role of Plasma Galactomannan.

van de Groep K, Verboom DM, van de Veerdonk FL, Haas PA, van der Poll T, Schultz MJ, Bonten MJM, Cremer OL.

Am J Respir Crit Care Med. 2019 Sep 1;200(5):636-638. doi: 10.1164/rccm.201903-0587LE. No abstract available.

PMID:
31042411
35.

Decontamination Strategies for Critically Ill Patients-Reply.

Wittekamp BH, Plantinga NL, Bonten MJM.

JAMA. 2019 Apr 9;321(14):1410. doi: 10.1001/jama.2019.0456. No abstract available.

PMID:
30964524
36.

A diagnostic algorithm for the surveillance of deep surgical site infections after colorectal surgery.

Mulder T, Kluytmans-van den Bergh MFQ, van Mourik MSM, Romme J, Crolla RMPH, Bonten MJM, Kluytmans JAJW.

Infect Control Hosp Epidemiol. 2019 May;40(5):574-578. doi: 10.1017/ice.2019.36. Epub 2019 Mar 14.

37.

Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital.

Díaz-Agero Pérez C, López-Fresneña N, Rincon Carlavilla AL, Hernandez Garcia M, Ruiz-Garbajosa P, Aranaz-Andrés JM, Maechler F, Gastmeier P, Bonten MJM, Canton R.

BMJ Open. 2019 Mar 1;9(3):e024879. doi: 10.1136/bmjopen-2018-024879.

38.

[New antibiotics: an overview].

Lemkes BA, Richel O, Bonten MJ, van der Linden PD, Wiersinga WJ.

Ned Tijdschr Geneeskd. 2019 Feb 13;163. pii: D3107. Dutch.

PMID:
30816653
39.

Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.

Weiss E, Zahar JR, Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Torres A, Wunderink RG, Timsit JF.

Clin Infect Dis. 2019 Nov 13;69(11):1912-1918. doi: 10.1093/cid/ciz093.

PMID:
30722013
40.

Profile of the SeptiCyte™ LAB gene expression assay to diagnose infection in critically ill patients.

Verboom DM, Koster-Brouwer ME, Varkila MRJ, Bonten MJM, Cremer OL.

Expert Rev Mol Diagn. 2019 Feb;19(2):95-108. doi: 10.1080/14737159.2019.1567333. Epub 2019 Feb 5. Review.

PMID:
30623693
41.

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.

Postma DF, Spitoni C, van Werkhoven CH, van Elden LJR, Oosterheert JJ, Bonten MJM.

BMC Infect Dis. 2019 Jan 7;19(1):17. doi: 10.1186/s12879-018-3630-7.

42.

Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.

van de Groep K, Nierkens S, Cremer OL, Peelen LM, Klein Klouwenberg PMC, Schultz MJ, Hack CE, van der Poll T, Bonten MJM, Ong DSY; MARS consortium.

Crit Care. 2018 Dec 18;22(1):348. doi: 10.1186/s13054-018-2261-0.

43.

Myocardial Injury in Critically Ill Patients with Community-acquired Pneumonia. A Cohort Study.

Frencken JF, van Baal L, Kappen TH, Donker DW, Horn J, van der Poll T, van Klei WA, Bonten MJM, Cremer OL; Members of the MARS Consortium.

Ann Am Thorac Soc. 2019 May;16(5):606-612. doi: 10.1513/AnnalsATS.201804-286OC.

PMID:
30521759
44.

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).

Ten Doesschate T, van Mens SP, van Nieuwkoop C, Geerlings SE, Hoepelman AIM, Bonten MJM.

BMC Infect Dis. 2018 Dec 5;18(1):626. doi: 10.1186/s12879-018-3562-2.

45.

The quality of studies evaluating antimicrobial stewardship interventions: a systematic review.

Schweitzer VA, van Heijl I, van Werkhoven CH, Islam J, Hendriks-Spoor KD, Bielicki J, Bonten MJM, Walker AS, Llewelyn MJ; Consensus on Antimicrobial Stewardship Evaluations (CASE) study group.

Clin Microbiol Infect. 2019 May;25(5):555-561. doi: 10.1016/j.cmi.2018.11.002. Epub 2018 Nov 23.

PMID:
30472426
46.

Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.

Schweitzer VA, van Werkhoven CH, van Heijl I, Smits RF, Boel CHE, Bonten MJM, Postma DF, Oosterheert JJ.

Neth J Med. 2018 Nov;76(9):389-396.

47.

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls.

van Werkhoven CH, Harbarth S, Bonten MJM.

Intensive Care Med. 2019 May;45(5):678-682. doi: 10.1007/s00134-018-5426-z. Epub 2018 Oct 30. No abstract available.

48.

Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial.

Wittekamp BH, Plantinga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J, Wise MP, Morgan MPG, Depuydt P, Boelens J, Dugernier T, Verbelen V, Jorens PG, Verbrugghe W, Malhotra-Kumar S, Damas P, Meex C, Leleu K, van den Abeele AM, Gomes Pimenta de Matos AF, Fernández Méndez S, Vergara Gomez A, Tomic V, Sifrer F, Villarreal Tello E, Ruiz Ramos J, Aragao I, Santos C, Sperning RHM, Coppadoro P, Nardi G, Brun-Buisson C, Bonten MJM.

JAMA. 2018 Nov 27;320(20):2087-2098. doi: 10.1001/jama.2018.13765.

49.

[A trial to study the effect of influenza vaccination in the elderly: ethical, feasible and badly needed].

Ekkelenkamp MB, van Werkhoven CH, Bruijning-Verhagen PCJ, Bonten MJM.

Ned Tijdschr Geneeskd. 2018 Sep 6;162. pii: D3285. Dutch.

PMID:
30306759
50.

Antibiotic treatment of gastroenteritis in primary care.

Schierenberg A, Bruijning-Verhagen PCJ, van Delft S, Bonten MJM, de Wit NJ.

J Antimicrob Chemother. 2019 Jan 1;74(1):207-213. doi: 10.1093/jac/dky385.

PMID:
30285243

Supplemental Content

Loading ...
Support Center